Pterigion surgery: San José Hospital in Bogotá DC
Cirugía de pterigio: Hospital de San José de Bogotá DC
Show authors biography
Pterygium, non-involuntary corneal degeneration, is an inflammatory and proliferative alteration of the ocular surface with thickening and elastotic degeneration of the conjunctiva. Exposure to ultraviolet solar radiation, heat, dust and viral agents participate in its evolution. Objective: to describe the results of pterygium surgery at the San José Hospital in Bogotá DC. Method: case series of all patients with this diagnosis operated between January 2010 and December 2011. Results: 176 stories were reviewed and 113 eyes were included. The most frequent complications were corneal del 7.9%, reproduction 5% and retraction of plasty 3.5%, identified in the first three months postoperatively. The reproduction frequency was higher in the cases of pterygium reproduced (33%), compared to the primary 4.4%. Conclusion: despite the known side effects of mitomycin, those who used it in the postoperative period in low doses did not present adverse effects and its use was safe. Given the low percentage of reproduction in this study, it is recommended that in the resection of extensive or reproduced pterigios, the use of amniotic membrane be considered.
Article visits 730 | PDF visits 311
Downloads
1. Arenas E. ¿Qué es un pterigión reproducido en la era actual? . Arch Soc Esp Oftalmol. 2012;87(5):137-8.
2. Rojas-Ávarez E. Cirugía del pterigion: una historia que aún no termina. Arch Soc Esp Oftalmol. 2008;83(5):333-4.
3. Smolin G, Foster CS, Azar DT, Dohlman CH, editors. Smolin and Thoft’s The Cornea: Scientific Foundations and Clinical Practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
4. Golu T, Mogoantă L, Streba CT, Pirici DN, Mălăescu D, Mateescu GO, Muţiu G. Pterygium: histological and Immunohistochemical aspects. Rom J Morphol Embryol. 2011; 52(1):153-8.
5. Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthal. 2001; 119(5): 695-706.
6. Harvard Eye Associates [página en Internet]. California: The Association; c2015. [citado 20 Feb 2015]. Pterygium No-Stitch Surgery; [aprox. 2 pantallas]. Disponible en: http://www.harvardeye.com/procedures/pterygium.html
7. Alvarez de Toledo Elizalde JP, Fideliz de la Paz DM. Pterigión: caso clínico y revisión. Arch. Soc. Canar Oftal [serie en Internet]. 2003 [citado 12 Ago 2002]; 14: [aprox. 3 p.]. Disponible en: http://www.oftalmo.com/sco/revista-14/14sco10.htm
8. Alemañy González J, Camacho Ruaigip F. Usos de la membrana amniótica humana en oftalmología. Rev Cubana Oftalmol.2006; 19(1): 1-7.
9. Viso E, Gude F, Rodríguez-Ares MT. Prevalence of pinguecula and pterygium in a general population in Spain. Eye (Lond). 2011 Mar;25(3):350-7.
10. Karabatsas CH, Marsh GW, Cook AM, Cook SD. Different therapeutic approaches and outcome in the treatment of pterygium. Eur J Ophthalmol. 1998 Jul-Sep;8(3):148-52.
11. Cardillo JA, Alves MR, Ambrosio LE, Poterio MB, Jose NK. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology. 1995 Dec;102(12):1949-52.